FDA recall Z-1019-2026

Meridian Bioscience Inc · Class II · device

Product

Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300

Reason for recall

The affected lots show a decline in performance over time, which may lead to false-negative results.

Distribution

US Nationwide distribution and the OUS country of Italy.

Key facts

Status
Ongoing
Initiation date
2025-12-05
Report date
2026-01-14
Voluntary/Mandated
Voluntary: Firm initiated
Location
Cincinnati, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1019-2026